Scott Braunstein - Feb 16, 2024 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC. (MRNS)

Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Stock symbol
MRNS
Transactions as of
Feb 16, 2024
Transactions value $
-$117,789
Form type
4
Date filed
2/21/2024, 04:05 PM
Previous filing
Jan 19, 2024
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Sale -$118K -11.9K -5.03% $9.94 224K Feb 16, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on May 16, 2022 to cover tax obligations in connection with the vesting of restricted stock units.
F2 The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.88 to $9.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.